Cargando…

Correction: Suramin: A Potential Therapy for Diabetic Nephropathy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237508/ http://dx.doi.org/10.1371/journal.pone.0114426

Ejemplares similares

Suramin: A Potential Therapy for Diabetic Nephropathy
por: Korrapati, Midhun C., et al.
Publicado: (2013)

Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2013)

Suramin Inhibits Chikungunya Virus Entry and Transmission
por: Ho, Yi-Jung, et al.
Publicado: (2015)

Long-Term Effects of Suramin on Renal Function in Streptozotocin-Induced Diabetes in Rats
por: Chyła-Danił, Gabriela, et al.
Publicado: (2023)

Correction for: MiR-320a induces diabetic nephropathy via inhibiting MafB
por: He, Mengying, et al.
Publicado: (2022)

Correction to: Circulating galectin-3 levels and diabetic nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023)

Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats
por: Chyła, Gabriela, et al.
Publicado: (2021)

Correction: Renal denervation in an animal model of diabetes and hypertension: Impact on the autonomic nervous system and nephropathy
por: Dias, Lucinara D, et al.
Publicado: (2011)

Correction: In-silico analysis of interacting pathways through KIM-1 protein interaction in diabetic nephropathy
por: Abid, F., et al.
Publicado: (2022)

Suramin Inhibits Hsp104 ATPase and Disaggregase Activity
por: Torrente, Mariana P., et al.
Publicado: (2014)

Suramin Alleviates Glomerular Injury and Inflammation in the Remnant Kidney
por: Liu, Na, et al.
Publicado: (2012)

Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
por: von der Ahe, David, et al.
Publicado: (2018)

Delayed administration of suramin attenuates peritoneal fibrosis in rats
por: Xiong, Chongxiang, et al.
Publicado: (2019)

1984—Discovery of the First Anti-HIV Drug, Suramin
por: De Clercq, Erik
Publicado: (2021)

Correction: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
por: Izadi, Morteza, et al.
Publicado: (2023)

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
por: Ren, Peijun, et al.
Publicado: (2014)

Correction to: Beraprost Sodium Delays the Decline of Glomerular Filtration Rate in Patients with Diabetic Nephropathy: A Retrospective Study
por: Zhou, Jingjing, et al.
Publicado: (2023)

Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes
por: Chyła-Danił, Gabriela, et al.
Publicado: (2023)

Effect of suramin on differentiation of human stomach cancer cell lines.
por: Choe, G., et al.
Publicado: (1997)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Structure of Trypanosome Coat Protein VSGsur and Function in Suramin Resistance
por: Zeelen, Johan, et al.
Publicado: (2021)

Initiation and modulation of Tau protein phase separation by the drug suramin
por: Prince, Prabhu Rajaiah, et al.
Publicado: (2023)

Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy
por: van Ark, Joris, et al.
Publicado: (2013)

Correction: Proteasome subunit-α type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy
por: Feng, Ying, et al.
Publicado: (2019)

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
por: Henß, Lisa, et al.
Publicado: (2016)

Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathy
por: Westermann, Lukas, et al.
Publicado: (2023)

Correction to: New-onset IgA nephropathy following COVID-19 vaccination
Publicado: (2022)

Correction: miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells
por: Gondaliya, Piyush, et al.
Publicado: (2019)

Correction: MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy
por: Zhou, Zhanmei, et al.
Publicado: (2018)

Correction to: METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α‑klotho
por: Li, Manna, et al.
Publicado: (2022)

Ectodomain Lysines and Suramin Block of P2X(1) Receptors
por: Sim, Joan A., et al.
Publicado: (2008)

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.
por: De Giovanni, C., et al.
Publicado: (1995)

Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin
por: Nardone, Valentina, et al.
Publicado: (2020)

Correction: Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models
por: Huang, Kaipeng, et al.
Publicado: (2012)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Correction: Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
por: Liu, Chun Xi, et al.
Publicado: (2022)

Author Correction: p66Shc: A novel biomarker of tubular oxidative injury in patients with diabetic nephropathy
por: Xu, Xiaoxuan, et al.
Publicado: (2020)

Correction: Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ
Publicado: (2015)

Correction: Mangiferin Attenuates Diabetic Nephropathy by Inhibiting Oxidative Stress Mediated Signaling Cascade, TNFα Related and Mitochondrial Dependent Apoptotic Pathways in Streptozotocin-Induced Diabetic Rats
Publicado: (2014)

Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK‐Ay mice
por: Oda, Kaori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mclk2jg7ecv502q49h69ac8ucl